Clinical use of plasma chitotriosidase in severe sepsis.

Link to article at PubMed

Clinical use of plasma chitotriosidase in severe sepsis.

Curr Med Res Opin. 2015 Nov 9;:1-14

Authors: Chiarla C, Giovannini I, Antuzzi D, Piras A, Ardito F, Giuliante F

Abstract
Plasma chitotriosidase activity (ChT) was previously proposed to quantify severity of sepsis. In a complex surgical case, with prolonged sepsis and consistently high ChT, we found that the least increased values occurred in stages of extreme illness, with profound hypocholesterolemia. ChT needs a better characterization before becoming a reliable biomarker of septic evolution.

PMID: 26550788 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *